Statera Biopharma, Inc. (STAB)

USD 0.0

(0.0%)

Gross Profit Summary of Statera Biopharma, Inc.

  • Statera Biopharma, Inc.'s latest annual gross profit in 2021 was -488.31 Thousand USD , down 0.0% from previous year.
  • Statera Biopharma, Inc.'s latest quarterly gross profit in 2022 Q3 was 501.11 Thousand USD , down -11.76% from previous quarter.
  • Statera Biopharma, Inc. reported a annual gross profit of - USD in annual gross profit 2020, down 0.0% from previous year.
  • Statera Biopharma, Inc. reported a annual gross profit of - USD in annual gross profit 2019, down 0.0% from previous year.
  • Statera Biopharma, Inc. reported a quarterly gross profit of 644.16 Thousand USD for 2022 Q1, down -26.64% from previous quarter.
  • Statera Biopharma, Inc. reported a quarterly gross profit of 501.11 Thousand USD for 2022 Q3, down -11.76% from previous quarter.

Annual Gross Profit Chart of Statera Biopharma, Inc. (2021 - 2006)

Historical Annual Gross Profit of Statera Biopharma, Inc. (2021 - 2006)

Year Gross Profit Gross Profit Growth
2021 -488.31 Thousand USD 0.0%
2020 - USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD -100.0%
2011 8.79 Billion USD 61172.89%
2010 14.34 Million USD 0.0%
2009 - USD 0.0%
2008 - USD -100.0%
2007 2.01 Million USD 18.17%
2006 1.7 Million USD 0.0%

Peer Gross Profit Comparison of Statera Biopharma, Inc.

Name Gross Profit Gross Profit Difference
America Great Health 168.58 Thousand USD 389.649%
Ampio Pharmaceuticals, Inc. -250 Thousand USD -95.326%
Aridis Pharmaceuticals, Inc. - USD Infinity%
Biora Therapeutics, Inc. -551 Thousand USD 11.377%
Bio-Path Holdings, Inc. -178 Thousand USD -174.334%
Better Therapeutics, Inc. -2.72 Million USD 82.106%
Calithera Biosciences, Inc. -1.38 Million USD 64.743%
Comera Life Sciences Holdings, Inc. 422.71 Thousand USD 215.519%
Gene Biotherapeutics, Inc. - USD Infinity%
eFFECTOR Therapeutics, Inc. -22.91 Million USD 97.869%
Eloxx Pharmaceuticals, Inc. - USD Infinity%
Evelo Biosciences, Inc. - USD Infinity%
Evolutionary Genomics, Inc. -1.02 Million USD 52.196%
Finch Therapeutics Group, Inc. -7.09 Million USD 93.115%
Galera Therapeutics, Inc. -259 Thousand USD -88.538%
Innovation1 Biotech Inc. -52.69 Thousand USD -826.627%
Kiromic BioPharma, Inc. -2.79 Million USD 82.535%
Molecular Templates, Inc. 50.39 Million USD 100.969%
Navidea Biopharmaceuticals, Inc. -119.29 Thousand USD -309.333%
NexImmune, Inc. -1.02 Million USD 52.358%
Orgenesis Inc. -5.72 Million USD 91.47%
Panbela Therapeutics, Inc. -25.64 Million USD 98.096%
Point of Care Nano-Technology, Inc. -4601.00 USD -10513.215%
PaxMedica, Inc. Common Stock - USD Infinity%
Scopus BioPharma Inc. - USD Infinity%
Sorrento Therapeutics, Inc. 29.38 Million USD 101.662%
TRACON Pharmaceuticals, Inc. -232 Thousand USD -110.48%
Trevena, Inc. 1.45 Million USD 133.561%
Vaxxinity, Inc. -2.23 Million USD 78.142%
Vaccinex, Inc. -16 Million USD 96.949%
Vicapsys Life Sciences, Inc. - USD Infinity%
Viracta Therapeutics, Inc. -492 Thousand USD 0.749%
ZIVO Bioscience, Inc. 11.61 Thousand USD 4305.978%